Specialized pharmaceutical manufacturer Jeronselvain announced on the 24th that it has signed an exclusive distribution agreement with Medincode Medical, a leading medical and cosmetics distribution company in T?rkiye.
Through this agreement, Jeronselvain plans to stably supply its pharmaceutical product ‘Selvain Injection’ and cosmetics ‘Selvain Cosmetic’ and ‘Selvain Skin Booster’ to the Turkish market, providing high-quality products to local consumers.
Medincode Medical supplies products from various brands to the local market based on its extensive network and expertise in the medical and cosmetics distribution sectors in T?rkiye. Leveraging its strong distribution network with government and regulatory agencies within T?rkiye, it aims to maximize synergy in brand expansion and market share growth.
In particular, T?rkiye has established itself as a hub connecting Europe and the Middle East, and Jeronselvain is currently undergoing local Food and Drug Administration (FDA) approval procedures for market entry. Once approval is completed, market expansion is expected to accelerate.
Kim Deok-gyu, CEO of Jeronselvain, stated, “Through this exclusive distribution agreement, we aim to strengthen Jeronselvain’s brand awareness and expand market share,” adding, “We expect Jeronselvain’s products to enter the local market more effectively.”
He continued, “By collaborating with Medincode Medical, we will establish strategies optimized for the local market and achieve continuous growth,” and added, “This will be an important milestone in solidifying our position in the global market, and we plan to actively pursue the development of various overseas markets in the future.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
